Even though it cannot be excluded that, at least in some cases, cellular responses could be due not only to a direct effect on NPM1 and its interactors but also to indirect effects like those following DNA damage, it is clear from these studies that NPM1 targeting may be a powerful strategy for treating a number of tumours of diverse histological origin. The gene discussed is NPM1; the disease is neoplasm.